Work

Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): One-Year Safety and Efficacy Outcomes from a Multicenter Phase I Trial

Year: 2023

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2023.06.638

Authors: S. McClelland III, T. Lautenschlaeger, A.C. Miller, Y. Zang, K.I. Lauer, N. Hanna, R.M. Rhome, N. Agrawal, P.A. Anthony, J.J. Jaboin, K. Shiue, G. Watson

Institutions: University Hospitals Seidman Cancer Center, Case Western Reserve University, Indiana University School of Medicine, Indiana University, Indiana University Indianapolis, Oregon Health & Science University

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387207607

FWCI: 0.367

Cites:

Cited by: 2

Related to: 10